Clinical Trial Update: Phase II Trial of Pemetrexed-Based Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Previously Irradiated Head and Neck Cancer Patients [Phase 2]

View source ↗

Summary

Phase II trial of pemetrexed-based induction chemotherapy followed by chemoradiotherapy in previously irradiated head and neck cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

Sponsor: University of Chicago | Conditions: Head and Neck Cancer | Phase 2 | Status: COMPLETED